Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition
Description
Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition
This new edition provides a wealth of financial deal terms that can provide those in the middle of technology negotiations with real-world pricing guidance.
The ninth edition of Royalty Rates for Pharmaceuticals & Biotechnology continues to focus on the financial terms and royalty rates associated with biotechnology and pharmaceutical intellectual property transfers. This report is a tool that can be used as guidance for the pricing of biotechnology and pharmaceutical intellectual property. The information in this resource is also useful for the valuation of patents and establishing damages for infringement litigation.
This report features financial information about real world third-party transactions that center on the transfer of biotechnology and pharmaceutical intellectual property - royalty rates, upfront license fees, and milestone payments.
The transaction information presented in this new edition has been collected from well-established sources believed to be reliable for the past three decades from September 1990 through February 2022. The parties involved in each reported transaction are disclosed along with a description of the technology exchanged and all of the financial details that could be discovered. For this new edition we have emphasized the reporting of royalty rates and other financial compensation associated with license agreements. We have updated and expanded information that was reported in past editions and conducted extensive research to expand the number of license agreements reported.
The database covers a wide variety of technologies. Just some of the technology categories represented in the database address: Agriculture, Alcohol Dependency, Alzheimer’s, Anesthetics, Attention Deficit Disorder, Anti-inflammatory, Arthritis, Asthma, Blood Expander, Cancer, Cardiovascular, Cold Remedies, Contraceptives, Dermatology, Diabetes, Diagnostics, Drug Delivery, Gene Activation, Hepatitis A, B & C, HIV, Kidney Disease, Monoclonal Antibodies, Neurological, Nucleic Acid, Pain Management, Personal Care, Polymerase Chain Reaction Technology, Psychiatric, Recombinant Technology, Sexual Dysfunction, Sleep Therapy, Stem Cell Therapy, Sterile Burn Dressings, Tamiflu, Vaccines, and Wart Removal.
This new edition provides a wealth of financial deal terms that can provide those in the middle of technology negotiations with real-world pricing guidance.
The ninth edition of Royalty Rates for Pharmaceuticals & Biotechnology continues to focus on the financial terms and royalty rates associated with biotechnology and pharmaceutical intellectual property transfers. This report is a tool that can be used as guidance for the pricing of biotechnology and pharmaceutical intellectual property. The information in this resource is also useful for the valuation of patents and establishing damages for infringement litigation.
This report features financial information about real world third-party transactions that center on the transfer of biotechnology and pharmaceutical intellectual property - royalty rates, upfront license fees, and milestone payments.
The transaction information presented in this new edition has been collected from well-established sources believed to be reliable for the past three decades from September 1990 through February 2022. The parties involved in each reported transaction are disclosed along with a description of the technology exchanged and all of the financial details that could be discovered. For this new edition we have emphasized the reporting of royalty rates and other financial compensation associated with license agreements. We have updated and expanded information that was reported in past editions and conducted extensive research to expand the number of license agreements reported.
The database covers a wide variety of technologies. Just some of the technology categories represented in the database address: Agriculture, Alcohol Dependency, Alzheimer’s, Anesthetics, Attention Deficit Disorder, Anti-inflammatory, Arthritis, Asthma, Blood Expander, Cancer, Cardiovascular, Cold Remedies, Contraceptives, Dermatology, Diabetes, Diagnostics, Drug Delivery, Gene Activation, Hepatitis A, B & C, HIV, Kidney Disease, Monoclonal Antibodies, Neurological, Nucleic Acid, Pain Management, Personal Care, Polymerase Chain Reaction Technology, Psychiatric, Recombinant Technology, Sexual Dysfunction, Sleep Therapy, Stem Cell Therapy, Sterile Burn Dressings, Tamiflu, Vaccines, and Wart Removal.
Table of Contents
- Licensing Deals Contents
- 1,2-diphenylethanes, 1,3-diphenylpropanes and benzyl tetralins
- Abuse Deterrent
- Actimmune - interferon gamma-1b
- Adult Growth Hormone Deficiency
- Agriculture – Animal Health/Trilostane
- Agriculture – Golden Rice
- Alcohol Dependency Treatment
- Aldurazyme - recombinant form of the human enzyme alpha-L-iduronidase
- Alpha Interferon – Natural
- Alzheimer's Diagnostic Test
- Alzheimer’s Treatment
- Alzheimer’s Treatment
- Alzheimer’s Treatment
- Alzheimer’s Treatment
- Alzheimer’s Treatment
- Alzheimer’s Treatment
- Alzheimer’s Treatment
- Alzheimer’s Treatment
- Alzheimer’s Treatment
- Anemia
- Anesthetic
- Animal Health Products
- Antibiotic – Brilacidin
- Antibiotic – Monoclonal
- Antibodies - Primatized
- Antibodies - Primatized
- Antibodies - Primatized Anti-CD4
- Antibiotic – VIBATIV®
- Anti-hypertension Therapy
- Anti-infection Screening Process
- Anti-inflammatory Drug BB-882
- Anti-inflammatory – Topical
- Antifungal Agent – Amphotericin B
- Antifungal
- Anti-retroviral medicine - Viread
- Anti-viral Barrier
- Anti-viral – COVID-19 Treatment
- Anti-viral – COVID-19 Treatment
- Anti-viral – COVID-19 Vaccine
- Anti-viral – COVID-19
- Anti-viral – COVID-19
- Anti-viral Therapy
- Anti-viral and Anti-infective Therapies
- Antiviral and Anti-infective Therapies
- Arginine Products
- Arthritis – Rheumatoid - Drug Humira
- Asthma Drug – Oral Administration
- Asthma Drug – Oral Administration
- Attention Deficit Hyperactivity Disorder Therapy
- Attention Deficit Hyperactivity Disorder
- Attention Deficit Hyperactivity Disorder
- Autoimmune Disease Therapy
- Automated Cell Processing Instrument
- Automated Process Research
- Bacterial Infections
- Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition
- BetaKine (TGF-beta-2)
- Bicifadine
- Biochemical Technology Portfolio
- Blood Cell and Bone Marrow Production
- Blood Cell Therapy
- Blood Clot Treatment
- Blood Clot Formation Test
- Blood Expander
- Blood Expander
- Blood Expander
- Blood – Hematology Controls Using Reticuulotytes
- Blood – Hemophilia B
- Blood Plasma Volume Expander
- BPI – Human Protein
- Cancer
- Cancer
- Cancer
- Cancer
- Cancer - ADCETRIS
- Cancer Diagnostics
- Cancer Research Technology
- Cancer Treatment – Brain Malignancy
- Cancer LukemiaTreatment
- Cancer Treatment
- Cancer Treatment
- Cancer Treatment
- Cancer Treatment
- Cancer Treatment
- Cancer Treatment
- Cancer Treatment
- Cancer Treatment
- Cancer Treatment – 9-Aminocamptothecin
- Cancer - Aflibercept
- Cancer – Alfa Interferone
- Cancer Therapy – AKT-mTOR Pathway
- Cancer – ALTR1550
- Cancer – AMD473
- Cancer – Anticancer ImmunityTreatment
- Cancer Treatment - Antisense Oligonucleotides
- Cancer Treatment – B-CLL
- Cancer Treatment – Bladder
- Cancer Treatment – Basal Cell Carcinoma Nevus Syndrome
- Cancer Treatment – Blood Cells
- Cancer – Brain
- Cancer – Brain
- Cancer Treatment – Carbohydrate Compounds
- Cancer Treatment – Clofarabine
- Cancer Treatment – Colorectal and Pancreatic
- Cancer Treatment – Colorectal and Pancreatic
- Cancer Therapy – Diagnostics
- Cancer Treatment – Doxorubicin Resistant Tumors
- Cancer – Ceeplen® Leukemia Treatment
- Cancer Treatment – Cervical Cancer
- Cancer Treatment – Colorectal Cancer
- Cancer Treatment – CRx-026
- Cancer Treatment – DBD/Mitolactol
- Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition
- Cancer Therapy – Delivery
- Cancer Therapy
- Cancer Therapy – Delivery
- Cancer Treatment – Disodium Clodronate
- Cancer Treatment – Electrostatic Lipsome
- Cancer Treatment – Endometrial
- Cancer Treatment – Epidermal Growth Factor
- Cancer Treatment – Foscan
- Cancer Treatment – Gliadel
- Cancer - Hedgehog Pathway Inhibitor
- Cancer- Histone Deacetylase (HDAC) Inhibitors
- Cancer Treatment – Immunosuppressive Microenvironment
- Cancer Treatment – Lymphocytic Leukemia
- Cancer Treatment – huN901-DM1 Tumor-Activated Prodrug (TAP)
- Cancer Treatment – IFN-Gamma Susceptible Diseases
- Cancer Treatment – Kaposi’s Sarcoma
- Cancer Treatment – Lung Cancer
- Cancer Treatment – Lung Cancer
- Cancer Treatment – Lung Cancer
- Cancer Treatment – Lymphoblastic Leukemia
- Cancer Treatment – Maytansinoid Tumor-Activated Prodrug (TAP)
- Cancer Therapy – Metastic Melanoma
- Cancer Therapy – Monoclonal Antibody
- Cancer Treatment – Keytruda
- Cancer Therapy – Lymphomam B Cell Non-Hodgkin’s
- Cancer Therapy – Lymphoma
- Cancer Therapy – Mouse
- Cancer Therapy – Multiple Melanoma, Relapsed
- Cancer Therapy – Myelodysplastic Syndrome
- Cancer Therapy - Myelomonocytic Leukemia
- Cancer Therapy - NeoRx's Avicidin®
- Cancer Treatment – Nexavar™
- Cancer Treatment – Non-small Cell Lung
- Cancer Treatment – Oncolysin B
- Cancer Treatment - Optisomes
- Cancer Treatment - Optisomes
- Cancer Therapy – Oral Mucositis Treatment
- Cancer Treatment OSI-774
- Cancer Therapy – Ovarian Cancer
- Cancer Treatment – Oxygen Enhancement
- Cancer Therapy – Pancreatic
- Cancer Therapy – Phenoxodiol
- Cancer Therapy – Prolanta™ Manufacturing Process
- Cancer Treatment - Prostate
- Cancer Therapy – Radiation Drug
- Cancer Treatment – Radio Labeled Antibody
- Cancer Treatment - Ribonucleases
- Cancer - Rhabdomyosarcoma
- Cancer - Treatment
- Cancer – TGF
- Cancer - Tarceva
- Cancer – Tumore Treatment
- Cancer – Tyrosine Kinase Inhibitor
- Cancer Treatment – Urinary Tract
- Cancer Treatment - Vaccines
- Cancer Treatment - Vaccines
- Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition
- Cancer Therapy
- Cancer Tumor Treatment
- Cannabinoid Receptor Meditating Compounds
- Cardiovascular
- Cardiovascular – Adenocard
- Cardiovascular – Angina
- Cardiovascular – Angina
- Cardiovascular – Angina
- Cardiovascular – Arrhythmias
- Cardiovascular – Atherosclerosis
- Cardiovascular – Blood Pressure and Cholesterol
- Cardiovascular – Beta Blocker
- Cardiovascular – Beta Blocker
- Cardiovascular – Beta Blocker
- Cardiovascular – Bextra™
- Cardiovascular – Blood Thinner
- Cardiovascular – Blood Thinner
- Cardiovascular – Blood Pressure and Cholesterol
- Cardiovascular – Cell Transplant Treatment
- Cardiovascular – Cholesterol
- Cardiovascular – Cholesterol
- Cardiovascular – Elafin™
- Cardiovascular – Endothelial Dysfunction
- Cardiovascular – Heart Cell Growth
- Cardiovascular – Heart Cell Growth
- Cardiovascular – Heart Cell Growth
- Cardiovascular – Hypertension
- Cardiovascular – Hypertension
- Cardiovascular – Hypertension
- Cardiovascular – Hypertension
- Cardiovascular – Hypertension
- Cardiovascular – Hypertension
- Cardiovascular – Hypertrophy
- Cardiovascular Nebulizer
- Cardiovascular – Risk Reduction
- Cardiovascular – Synthetic Heart Graft Drug
- Cardiovascular – Thrombosis Therapy
- Cardiovascular – Thrombosis Therapy
- Cardiovascular Generic Drug – ThromboClear
- Cardiorenal Disease Therapies
- Cartilage Regenerative Technology
- Catheter Technology
- cdkl Assay
- Coronary Drug-eluting Stent
- Cell Adhesion Technology – LEC-CAM
- Cell Cultures
- Chimeric IgG1 antibodies
- Cholesterol High LDL Treatment
- Cholesterol Treatment
- Chromosome Analysis Technology
- Crohn’s Disease Therapy
- Chronic Obstructive Pulmonary Disease Therapy
- COPD Treatment
- Cochleates, Liposomes and Proteoliposomes
- Cold Remedy
- Cold Remedy
- Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition
- Collagenase Ointment
- Consensus Interferon
- Contraceptive
- Contraceptive
- Contrast Agent – Intravenous
- Cough Medicine
- Cyclin Dependent Kinasc Assay Test Kit
- Cypress Stem Cells
- Cystic Fibrosis Treatment
- Cytomegalovirus Intravenous Treatment
- Deferrum® deferiprone
- Dermatology
- Dermatology
- Diabetes
- Diabetes
- Diabetes
- Diabetes
- Diabetes
- Diabetes – CIPD Treatment
- Diabetes
- Diabetes
- Diabetes
- Diabetes – Diabetic Peripheral Neuropathy
- Diabetes – Juvenile
- Diabetes – Glumetza
- Diabetic Macular Edema
- Diabetes – Pulmonary Administration of Insulin
- Diabetes – Type II
- Diabetes – Type II
- Diabetes – Type II
- Diabetes (Type II) Mellitus Drug
- Diabetes – PARL gene
- Diagnostic Alliance
- Diagnostic Imagining Using Ligands
- Dietary Supplement – Botanical
- Diltiazem Heart Drug
- DNA Synthesis
- DNA Binding Invention
- DNA Nanocircles
- DNA – PK
- Drug Delivery – Viral Infections
- Drug Delivery
- Drug Delivery
- Drug Delivery
- Drug Delivery – Topical
- Drug Delivery
- Drug Delivery – Controlled Release
- Drug Delivery System - Pulmonary
- Drug Development Technology
- Drug Development, Botanical-based
- EGF Fusion Protein
- Enoxaparin
- Environmental Test Kit
- Enzyme Inhibitors
- Epilepsy Treatment – ADCI
- EPO, Hepatitis B and IL-2
- Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition
- Erectial Dsyfuction Therapy – Vitaros™
- Erythronmycin Antibiotic
- Estrogen Replacement Therapy
- Fertility Treatment
- Fibrotic Disease Therapy - Pirfenidone
- Financing Research
- Financing Research
- Fusion Inihibitors for HIV
- Gastroretentive Drug Delivery Devices for Oral Intake
- Gastrointestinal Infection
- Gene Activation Technology
- Genetic Abnormalities Test – Prenatal
- Gene Alteration Technology
- Gene Splicing Technology
- Genetically Engineered Listeria Immune Therapy
- Genetic Research
- Gene Sequencing
- Gene Therapy Partnership Network
- Genetic Technology
- Genomics-based Drug Discovery
- Glycogen Storage Disease III
- Hepatitis
- Hepatitis
- Hepatitis A Vaccine
- Hepatitis B
- Hepatitis B
- Hepatitis B
- Hepatitis B
- Hepatitis B
- Hepatitis B
- Hepatitis B
- Hepatitis B
- Hepatitis B
- Hepatitis B and C Genetic Therapy
- Hepatitis B & C
- Hepatitis C
- Hepatitis C
- Hepatitis C
- Hepatitis C
- Hepatitis C
- Hepatitis C
- Hepatitis C
- Hepatitis C
- Hepatitis C
- Hepatitis C
- Hepatitis C
- Hepatitis C - Telaprev
- Hepatitis E Vaccine
- Hereditary Angioedema
- Hereditary ATTR (hATTR) amyloidosis.
- HIV Drugs
- HIV Drugs
- HIV and AIDS – Protease Inhibitor Therapy
- HIV Treatment – alpha interferon
- HIV Treatment – Interferon-g
- HIV Treatment – (NNRTI)
- Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition
- HIV Diagnosis and Treatment
- HIV and Hepatitis Vaccines
- HIV Vaccine
- HIV Virl-entry Inhibitor
- Human Gene Technology
- Human Growth Hormone
- Human Monoclonal Antibodies Discovery Technology
- Human Monoclonal Antibodu - Adalimumab
- Humanized Antibody
- Humanized Monoclonal Antibody
- Humanization Antibody
- Hypertension Treatment- autologous gene therapy
- Hypertension Treatment- tadalafil
- Inhaler Technology
- Inflammatory Diseases
- Immune System Enhancement
- Immune System Regulators – Cytokines
- Immunodeficiency
- Immunotoxin – MDX-RA
- Immune (idiopathic) Thrombocytopenic Purpura Therapy
- Immune (idiopathic) Thrombocytopenic Purpura Therapy
- Infections - Bacterial
- Indiplon
- Infertility Treatment - Male
- Inflammatory – Topical Therapy
- Inflammation Antibody-based Therapeutics
- Influenza Drug
- Insomnia Therapy
- Insomnia
- Intracellular Receptor Technology
- Integrelin Drug
- Interferon Gamma-1b
- Kidney Disease Treatment
- Kidney Disease Treatment
- Kidney Failure Treatment
- Liver Disease Therapy
- Liver Disease Therapy
- Living Cells Connective Tissue
- Lubrin®
- Lupus Nephritis
- Lung Problems (Emphysema) Treatment
- Lupis Nephritis
- mRNA Technology
- Macular Degeneration Therapy
- Macular Therapy – Spinal Muscular Atrophy
- Mammary Cell Growth Inhibitor
- Metabolic Treatment
- Metabolic Treatment
- Michellamine B/Tropical Vine Leaves
- Microorganism Detection in Water
- Microsponge Delivery System
- Migraine Relief
- Migraine Relief
- Modulation of Opioid Receptors
- Monoclonal Antibodies Binding to TGF-B
- Monoclonal Antibody Technology
- Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition
- Monoclonal Antibody Technology
- Monoclonal Antibody 45-J Test
- Monoclonal Antibodies to Gram Negative Sepsis-Related Bacteria
- Multiple Sclerosis
- Multiple Sclerosis – Relasping
- Multiple Sclerosis Therapy - Copaxone
- Naked DNA Technology
- Nanocrystalline Particles
- NASA Technology
- Nasal Decongestant
- Nasal Vitamin B-12 Therapy
- Natural Cell Signaling Phenomenon
- Neurological
- Neurological
- Neurological - DYRK1A syndrome
- Nerve Repair
- Nervous System Therapeutics
- Neurodegenerative and Psychiatric Diseases Therapy
- Neurological – Dravet Syndrone
- Neurological Depression Therapeutics
- Neurological Therapeutics
- Neurological Peptide Therapy
- Nicotine Addiction Treatment
- Nifedipine Crystals
- Novasome Lipid Vesicles Encapsulation Technology
- Nuclear Matrix Protein Technology
- Nucleic Acid Sequences for Detection
- Nucleic Acid Probe Technology
- Nucleic Acid Targeting
- Nucleic Acid Technologies
- NeuroCell Joint Venture
- Neurology - Menkes disease
- Neurological Disorders
- Nureologogical Disorders Anti-agitation Drug
- Nureologogical Disorders Anti-agitation Drug
- Neurotrophic Factor Commercialization
- Nutrition – Salt Alternative
- Obesity
- Obesity Therapy
- Opthalmic
- Opthalmic – Allergic Conjunctivitis
- Opthalmic – Dry Eye
- Opthalmic – Patent Formulation for Loteprednol Etabonate
- Oral Contraceptive
- Osteoarthritis Treatment for Animals
- Osteoporosis Compound 1-apiha-hydroxyvitamin D2
- Oxygenation
- Pain Management
- Pain Management
- Pain Management
- Pain Management
- Pain Management
- Pain Management
- Pain Management
- Pain Management
- Pain Management – Abuse Resistant
- Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition
- Pain Management
- Pain Management
- Pain Management
- Pain Management
- Pain Management
- Pain Management
- Pain Management
- Pain Management
- Pain Management
- Pain Management
- Pain Management
- Pain Management
- Pain Management
- Parkinson’s Disease
- PEG Enhanced L-asparaginase
- Pegylated Reagent
- Personal Care – Bioadhesive Delivery System
- Personal Care – Cosmetic Liposomal Formulations
- Personal Care – Facial Hair Treatment
- Personal Care – Hand Cleanser
- Personal Care – Kinetin™ Skin-Care Treatment
- Personal Care – Melanin Sunscreen Agent
- Personal Care – Moisturizers
- Personal Care – Moisturizers
- Personal Care – Mycrobicide Lotion
- Personal Care – Oral Treatment
- Personal Care – Serine Elastase Inhibitor Compound
- Personal Care – Skin Barrier Repair
- Personal Care – Skin Care Moisturizers
- Personal Care – Topical Antiseptics
- Personal Care – Various Products
- Pet Medication – Animal Feed
- Pet Medication – Bone Health
- Pet Medication – Crofelemer
- Pet Medication – Immunobiotic
- Pet Medication – Interferon-g ("IFN-g")
- Pet Medication – NK-92
- Pet Medication – Equidone
- Pet Medication – GI Field Technology
- Pet Medication – Trilostane
- Pet Medication – Trilostane
- Pet Medication – Trilostane
- Platinate HPMA Copolymer
- Pneumocystis Carinii Pneumonia
- Photodynamic Therapy
- Polymerase Chain Reaction Technology
- Polymerase Chain Reaction Technology
- Polymerase Chain Reaction Technology
- Poly (ADP Ribose) Polymerase Diagnostic Assay
- Pre-eclampsia/Toxemia Diagnosis and Therapy
- Primary Biliary Cholangitis
- Pro-Apolipoprotein A-I and Lipid Complexes
- Progesterone Gel
- Protein Secretion Technology
- Proteomics Technology
- Psychiatric & Psychotic Therapy
- Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition
- Psychotherapeutic Drugs
- Pulmonary Disease
- Radynilel Hypoxic Tumor Cell Radiosensitizer
- Rapid Diagnostic Test
- RAS Human Protein/Rational Drug Design
- Recombinant Technology
- Recombinant Human Erythropoietin- Procrit®
- Recombinant Human Inerlukin-twelve (rhIL-1 2)
- Respiratory Therapy
- Retinoids
- Rhenium Radiotherapy and Monoclonal Antibodies
- Ribozymes
- Rickets – x-linked hypophosphatemia treatment
- RNAi Interference Technology
- RNAi Interference Technology
- RNAi Interference Therapies
- Sarafem®
- Schizophrenia
- Schizophrenia and Bipolar Treatment
- Septic Shock Treatment - Human Thymosin beta 4 (Tβ4), a 43-amino acid peptide
- Sexual Dysfunction Therapy
- Skin Disorder
- Sleep Therapy
- Sleep Therapy – Nasal Administration
- Skin Technology - Polyactive Polymer Biomaterial
- Spirulina
- Spleen Tyrosine Kinase (Syk) Inhibitor
- Stem Cells
- Stem Cell Proliferation Factor
- Stem Cell Technology and Materials
- Stem Cells – Pluripotent Novel Strains
- Stem-loop Vector Technology
- Stromal Derived Factor 1 (SDF-1) Peptide Agonists and Antagonists
- Sugar Substitute
- Tamiflu™
- Telavancin™ – Antibotic
- Testosterone Replacement
- Testosterone Replacement
- Thalidomide
- Thalidomide Analogs
- Tissue Malignancy Treatments
- Thymidine Kinase Isoenzyme Diagnostics
- TGF-beta
- Topical Adminstration Technology
- Transdermal Estrogen Patch
- Tropical Plants
- Ultrasound Contrast Agent
- Vaccines, gene-based
- Vaccine Research
- Virus Prevention and Treatment - Coronavirus
- Virus Vaccines
- Wart Removal Products
- Water-Jel Sterile Burn Dressings
- Yeast-based Screening Technology
- Eli Lilly & Co. Experiences Compulsory License Royalty Rates
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
